Mark Kong CFA
Stock Analyst at DBS
(0.98)
# 3,792
Out of 4,592 analysts
23
Total ratings
31.3%
Success rate
-4%
Average return
Main Sectors:
Stocks Rated by Mark Kong CFA
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HKG: 1177 Sino Biopharmaceutical Limited | Initiated Coverage: Buy | $6.50 | $5.03 | +29.22% | 1 | May 20, 2026 | |
| HKG: 6160 BeOne Medicines AG | Maintained: Buy | $290.00 | $194.00 | +49.48% | 3 | May 7, 2026 | |
| HKG: 1681 Consun Pharmaceutical Group Limited | Maintained: Buy | $22.00 → $26.00 | $13.69 | +89.92% | 5 | Mar 27, 2026 | |
| HKG: 2105 Laekna, Inc. | Maintained: Buy | $24.16 | $6.05 | +299.34% | 6 | Mar 20, 2026 | |
| HKG: 1099 Sinopharm Group Co. Ltd. | Upgraded: Buy | $25.00 | $17.38 | n/a | 1 | Dec 12, 2024 | |
| HKG: 1515 China Resources Medical Holdings Company Limited | Maintained: Buy | $7.50 | $2.54 | n/a | 2 | Oct 24, 2024 | |
| SNY Sanofi | Maintained: Buy | n/a | $43.08 | n/a | 1 | Oct 11, 2024 | |
| VRTX Vertex Pharmaceuticals | Maintained: Hold | n/a | $477.10 | n/a | 2 | Oct 8, 2024 | |
| ABBV AbbVie | Maintained: Hold | n/a | $250.94 | n/a | 1 | Sep 13, 2024 | |
| MRNA Moderna | Maintained: Buy | n/a | $54.82 | n/a | 1 | Sep 13, 2024 |
Sino Biopharmaceutical Limited
May 20, 2026
Initiated Coverage: Buy
Price Target: $6.50
Current: $5.03
Upside: +29.22%
BeOne Medicines AG
May 7, 2026
Maintained: Buy
Price Target: $290.00
Current: $194.00
Upside: +49.48%
Consun Pharmaceutical Group Limited
Mar 27, 2026
Maintained: Buy
Price Target: $22.00 → $26.00
Current: $13.69
Upside: +89.92%
Laekna, Inc.
Mar 20, 2026
Maintained: Buy
Price Target: $24.16
Current: $6.05
Upside: +299.34%
Sinopharm Group Co. Ltd.
Dec 12, 2024
Upgraded: Buy
Price Target: $25.00
Current: $17.38
Upside: n/a
China Resources Medical Holdings Company Limited
Oct 24, 2024
Maintained: Buy
Price Target: $7.50
Current: $2.54
Upside: n/a
Sanofi
Oct 11, 2024
Maintained: Buy
Price Target: n/a
Current: $43.08
Upside: n/a
Vertex Pharmaceuticals
Oct 8, 2024
Maintained: Hold
Price Target: n/a
Current: $477.10
Upside: n/a
AbbVie
Sep 13, 2024
Maintained: Hold
Price Target: n/a
Current: $250.94
Upside: n/a
Moderna
Sep 13, 2024
Maintained: Buy
Price Target: n/a
Current: $54.82
Upside: n/a